SOURCE: Global Immune Technologies Inc.

May 04, 2010 00:54 ET

Global Immune Technologies Inc. Announces It Is in the Process of Becoming Relisted on the OTCBB and Also Planning an Acquisition in the Near Future

SEATTLE, WA--(Marketwire - May 4, 2010) - Global Immune Technologies Inc. ("the Company") (PINKSHEETS: GIMU) announced today that it has taken the steps necessary to become a fully reporting company on the OTCBB. The Company also announced it has begun discussions with several companies it is considering for acquisition, further analysis is required at this time to ensure the best opportunity for the shareholders is chosen. The Company is currently conducting due diligence on some very interesting prospects and it looks forward to announcing a decision in the near future. The Company also has verified that the current outstanding shares are 16,100,000 of which 11,600,000 are free trading. "The company is certainly excited that the market has expressed such an interest in our stock and progress as a company. We never anticipated such an overwhelmingly positive response," says Investor Relations Advisory Board. "We are working diligently to provide our shareholders with information which will be available on the Pinks Sheets until further notice," they continued.

Forward Looking Statements:
Included in this release are certain "forward-looking" statements, involving risks and uncertainties, which are covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding Global Immune Technologies Inc. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those referred to or implied by such statements. In addition, actual or future results may differ materially from those anticipated depending on a variety of factors, including continued maintenance of favorable license arrangements, success of market research identifying new product opportunities, successful introduction of new products, continued product innovation, sales and earnings growth, ability to attract and retain key personnel, and general economic conditions affecting consumer spending, Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Global Immune Technologies Inc. does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Safe Harbor:
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contact Information

  • Contact:
    Donald Perks
    Telephone: 1 902 459 1133